Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Non-Hodgkin Lymphoma (All Stages^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 19.0 (18.9, 19.0) N/A 71,841 falling falling trend -1.8 (-2.4, -1.3)
District of Columbia 6 14.5 (13.2, 15.9) 50 (44, 50) 98 falling falling trend -1.8 (-2.5, -1.1)
Wyoming 6 16.8 (15.4, 18.3) 43 (22, 49) 115 stable stable trend -0.6 (-1.3, 0.1)
Alaska 6 17.8 (16.4, 19.3) 36 (11, 46) 127 falling falling trend -1.2 (-2.1, -0.4)
North Dakota 6 18.3 (17.0, 19.7) 28 (10, 44) 158 stable stable trend -0.4 (-1.4, 0.5)
Vermont 6 19.0 (17.7, 20.5) 21 (7, 42) 161 stable stable trend 0.1 (-11.5, 13.1)
South Dakota 6 18.7 (17.5, 20.0) 24 (9, 42) 196 stable stable trend -0.5 (-1.2, 0.2)
Delaware 6 18.5 (17.4, 19.7) 26 (10, 42) 231 falling falling trend -4.2 (-7.1, -1.3)
Montana 6 17.8 (16.8, 18.9) 34 (15, 44) 245 falling falling trend -0.7 (-1.3, -0.1)
Rhode Island 6 19.1 (18.0, 20.2) 20 (8, 39) 253 stable stable trend -1.2 (-13.2, 12.3)
Hawaii 7 15.2 (14.4, 16.1) 47 (44, 50) 277 falling falling trend -2.7 (-4.1, -1.4)
New Hampshire 6 21.1 (20.1, 22.1) 8 (1, 14) 370 stable stable trend -0.2 (-0.8, 0.4)
New Mexico 7 14.5 (13.9, 15.2) 49 (46, 50) 375 falling falling trend -1.3 (-2.3, -0.2)
Idaho 7 19.3 (18.4, 20.2) 17 (8, 33) 378 stable stable trend -0.2 (-0.7, 0.2)
Maine 6 20.5 (19.5, 21.4) 9 (2, 21) 391 falling falling trend -0.5 (-1.0, -0.1)
Nebraska 6 20.1 (19.3, 21.0) 11 (4, 23) 449 stable stable trend -0.5 (-0.9, 0.0)
Utah 7 18.2 (17.5, 19.0) 31 (17, 41) 493 falling falling trend -1.1 (-1.9, -0.3)
West Virginia 6 19.9 (19.1, 20.7) 12 (6, 25) 498 stable stable trend -0.2 (-0.6, 0.3)
Puerto Rico 6 14.6 (14.1, 15.2) N/A 576 stable stable trend -1.2 (-5.4, 3.2)
Mississippi 6 16.9 (16.2, 17.5) 42 (34, 46) 583
*
*
Kansas 6 19.2 (18.5, 19.9) 19 (10, 31) 646 falling falling trend -0.6 (-1.1, -0.1)
Arkansas 6 18.5 (17.9, 19.2) 25 (15, 37) 680 stable stable trend 0.1 (-0.4, 0.5)
Oklahoma 6 17.4 (16.9, 18.0) 39 (28, 44) 790 falling falling trend -1.1 (-1.5, -0.7)
Iowa 7 21.2 (20.6, 21.9) 6 (2, 11) 817 stable stable trend -0.8 (-1.5, 0.0)
Oregon 6 18.2 (17.7, 18.8) 30 (20, 39) 934 falling falling trend -0.9 (-1.4, -0.4)
Alabama 6 15.8 (15.4, 16.3) 46 (43, 48) 943 falling falling trend -0.6 (-1.0, -0.2)
Connecticut 7 21.3 (20.7, 21.9) 5 (2, 10) 968 stable stable trend 0.1 (-0.1, 0.3)
South Carolina 6 16.1 (15.6, 16.6) 45 (42, 47) 998 falling falling trend -0.8 (-1.2, -0.4)
Louisiana 7 18.8 (18.2, 19.3) 23 (13, 33) 998 falling falling trend -1.1 (-1.7, -0.4)
Colorado 6 17.1 (16.6, 17.6) 41 (34, 44) 1,030 falling falling trend -1.0 (-1.3, -0.7)
Kentucky 7 19.6 (19.0, 20.1) 13 (9, 25) 1,050 falling falling trend -1.0 (-1.9, -0.1)
Maryland 6 17.8 (17.4, 18.3) 35 (25, 41) 1,248 stable stable trend -0.1 (-0.6, 0.4)
Arizona 6 15.0 (14.6, 15.4) 48 (46, 50) 1,291 falling falling trend -0.9 (-1.4, -0.4)
Missouri 6 18.5 (18.0, 18.9) 27 (19, 36) 1,384 stable stable trend -0.3 (-0.5, 0.0)
Minnesota 6 21.4 (20.9, 21.9) 4 (2, 9) 1,408 stable stable trend -0.2 (-0.6, 0.2)
Indiana 6 18.3 (17.8, 18.7) 29 (21, 38) 1,417 falling falling trend -4.3 (-6.9, -1.7)
Tennessee 6 17.7 (17.3, 18.1) 38 (27, 42) 1,429 falling falling trend -1.2 (-1.6, -0.7)
Wisconsin 6 21.1 (20.6, 21.6) 7 (2, 10) 1,508 stable stable trend 0.2 (-0.1, 0.5)
Massachusetts 7 19.0 (18.5, 19.4) 22 (13, 29) 1,588 falling falling trend -0.6 (-0.9, -0.3)
Virginia 6 16.7 (16.3, 17.0) 44 (40, 45) 1,624 falling falling trend -0.9 (-1.4, -0.5)
Washington 1 19.3 (18.9, 19.7) 16 (11, 26) 1,638 falling falling trend -1.2 (-1.4, -1.0)
Georgia 7 17.9 (17.6, 18.3) 33 (25, 40) 1,984 stable stable trend -2.3 (-4.8, 0.3)
North Carolina 6 17.8 (17.4, 18.1) 37 (28, 41) 2,161 stable stable trend -0.1 (-1.2, 1.0)
New Jersey 7 21.9 (21.5, 22.3) 2 (1, 6) 2,353 stable stable trend 0.0 (-0.2, 0.2)
Michigan 6 19.5 (19.1, 19.8) 14 (11, 23) 2,401 falling falling trend -0.9 (-1.3, -0.5)
Ohio 6 19.3 (19.0, 19.6) 15 (11, 25) 2,785 stable stable trend -0.2 (-0.5, 0.0)
Illinois 7 19.2 (18.9, 19.6) 18 (12, 25) 2,859 stable stable trend -0.2 (-0.5, 0.0)
Pennsylvania 6 20.4 (20.0, 20.7) 10 (7, 13) 3,387 falling falling trend -2.5 (-4.0, -1.0)
Texas 7 17.3 (17.1, 17.5) 40 (35, 43) 4,838 falling falling trend -1.2 (-1.3, -1.0)
New York 7 21.5 (21.2, 21.8) 3 (2, 8) 5,067 falling falling trend -0.4 (-0.7, -0.1)
Florida 6 22.5 (22.3, 22.8) 1 (1, 2) 6,497 falling falling trend -4.0 (-6.4, -1.4)
California 7 18.0 (17.8, 18.2) 32 (26, 37) 7,721 falling falling trend -1.7 (-2.5, -0.8)
Nevada 6
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 11/28/2022 12:11 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Nevada

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top